BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24503238)

  • 1. DNA damage checkpoints in nasopharyngeal carcinoma.
    Poon RY
    Oral Oncol; 2014 May; 50(5):339-44. PubMed ID: 24503238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage checkpoints in mammals.
    Niida H; Nakanishi M
    Mutagenesis; 2006 Jan; 21(1):3-9. PubMed ID: 16314342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
    Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
    Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage checkpoint control in cells exposed to ionizing radiation.
    Iliakis G; Wang Y; Guan J; Wang H
    Oncogene; 2003 Sep; 22(37):5834-47. PubMed ID: 12947390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of DNA damage checkpoints in the pathogenesis of human cancers.
    Poehlmann A; Roessner A
    Pathol Res Pract; 2010 Sep; 206(9):591-601. PubMed ID: 20674189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of EB virus latent membrane protein 1 on mitosis control of nasopharyngeal carcinoma cell line CNE1].
    Liu B; Chen XY
    Ai Zheng; 2004 May; 23(5):512-6. PubMed ID: 15142445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
    Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
    Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
    Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of cell cycle arrest in radiosensitization of nasopharyngeal carcinoma cell line CNE1 by inhibiting ATM expression].
    Wang HM; Chen LH; Zheng XK; Wu XY; Xia YF
    Ai Zheng; 2008 May; 27(5):466-70. PubMed ID: 18479594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
    Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF
    Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
    Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
    Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
    Zheng H; Li LL; Hu DS; Deng XY; Cao Y
    Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cell cycle in mediating sensitivity to radiotherapy.
    Pawlik TM; Keyomarsi K
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):928-42. PubMed ID: 15234026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative and localized detection of Epstein-Barr virus infectious status in nasopharyngeal carcinoma tissue].
    Jiang WH; Zhao SP; Yin ZH; Li F; Chen ZH; Xiao JY
    Ai Zheng; 2005 Jul; 24(7):796-800. PubMed ID: 16004803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
    Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J
    Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.